R. Naeije (Brussels, Belgium), M. Delcroix (Leuven, Belgium), C.D. Vizza (Rome, Italy), A. Vonk Noordegraaf (Amsterdam, The Netherlands)
Assessment of tissue velocity imaging of both ventricules in vasoreactive patients
E. Kobal, M. Saidova, N. Danilov, O. Arkhipova, T. Martynyuk, I. Chazova (Moscow, Russian Federation)
|  |
Subtle assessment of quality of life in PH patients on inhaled iloprost treatment
V. Reuber, H. Tiede, F. Reichenberger, R. Voswinckel, F. Grimminger, W. Seeger, A. Ghofrani (Giessen, Germany)
| |
The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension
G. Kovacs, C. Stöckl, A. Avian, X. Kqiku, V. Foris, M. Tscherner, H. Olschewski (Graz, Austria)
| |
Wrist actigraphy predicts outcome in patients with pulmonary hypertension
S. Ulrich, M. Fischler, R. Speich, K. E. Bloch (Zurich, Switzerland)
| |
Central venous-to-arterial carbon dioxide difference (CO2 GAP) in patients with arterial pulmonary hypertension: A pilot study
M. Rocha, F. Costa, J. E. Façanha Barreto (Fortaleza, Brazil)
| |
Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
N. Bonner, L. Abetz, J. Meunier, M. Sikirica (Bollington, United Kingdom; Lyon, France; Berlin, Germany)
| |
Modern age pathology of pulmonary arterial hypertension
E. Stacher, B. Graham, J. Hunt, A. Gandjeva, S. Groshong, V. McLaughlin, M. Jessup, W. Grizzle, C. Cool, R. Tuder (Graz, Austria; Aurora, Denver, Ann Arbor, Birmingham, United States Of America)
| |
The proANP increase during exercise may predict the PAP increase in connective tissue disease patients at risk of PAH
M. Tscherner, G. Kovacs, F. Fruhwald, R. Maier, B. Obermayer-Pietsch, A. Avian, V. Foris, H. Olschewski (Graz, Austria)
| |
Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
M. Szturmowicz, A. Kacprzak, M. Franczuk, A. Skoczylas, A. Fijalkowska, M. Kurzyna, S. Wesolowski, A. Torbicki (Warsaw, Poland)
| |
Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD
A. Goudie, P. Hopkinson, W. Anderson, B. Lipworth, A. Struthers (Dundee, United Kingdom)
| |
Telemetric right ventricular pressure measurements and serial echocardiography in experimental pulmonary arterial hypertension
M.A. de Raaf, I. Schalij, A. Vonk-Noordegraaf, F. de Man, H.J. Bogaard (Amsterdam, Netherlands)
| |
Correlation of computed tomography measurement of small puomonary vessels with hemodynamic factors in pulmonary arterial hypertension
Y. Matsuura, T. Sugiura, N. Kawata, N. Tanabe, K. Tatsumi (Chiba, Japan)
| |
Does lung function predict response to therapy in PAH associated with connective tissue disease?
C. Valerio, B. Schreiber, C. Handler, C. Denton, J. Coghlan (London, United Kingdom)
|  |
Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry
R. Zamanian, K. Kudelko, D. Miller, M. McGoon, R. Benza, P. Hassoun, M. Nicolls, L. Chung (Stanford, San Francisco, Rochester, Pittsburgh, Baltimore, Palo Alto, United States Of America)
| |
Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity
E. Nossent, P. Trip, H. J. Bogaard, A. Boonstra, A. Vonk-Noordegraaf, K. Grunberg (Amsterdam, Netherlands)
| |
Prognostic relevance of changes in exercise parameters in pulmonary arterial hypertension
H. Groepenhoff, A. Vonk-Noordegraaf, A. Boonstra, N. Westerhof, H. J. Bogaard (Amsterdam, Netherlands)
| |
Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension
G. Ruiter, A. Voskuyl, I. Lanser, F. de Man, P. Postmus, J. Wharton, N. Westerhof, W. van der Laarse, L. Howard, M. Wilkins, A. Vonk-Noordegraaf (Amsterdam, Netherlands; London, United Kingdom)
| |
The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
F. Reichenberger, R. Voswinckel, M. Thamm, F. Lendeckel, R. Schulz, M. Kappert, J. Dämming, R. Morty, C. Tanislav, H. A. Ghofrani, W. Seeger, H. Tiede (Giessen, München-Gauting, Germany)
| |
Novel method for assessment of the right ventricular contractile dysfunction in patients with severe COPD
O. Krakhmalova, D. Kalashnyk (Kharkiv, Ukraine)
| |
Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension
F. Kato, N. Tanabe, H. Kasai, A. Sekine, T. Takeuchi, T. Urushibara, R. Nishimura, R. Suda, T. Jujo, T. Sugiura, A. Shigeta, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba-shi, Japan)
| |